Massachusetts General Hospital Cancer Center

https://www.massgeneral.org/cancer-center

 

Massachusetts General Hospital Cancer Center
N

The Role of CDK4/6i in Endocrine Therapy of HR+/HER2- MBC: 1/2L Treatment Response in Pre/Postmenopausal Women

By Massachusetts General Hospital Cancer Center FEATURING Nancy Davidson
By Massachusetts General Hospital Cancer Center FEATURING Nancy Davidson
309 views
June 4, 2021
Comments 0
Login to view comments. Click here to Login
Grand Rounds
53:56

Oncologic Anthropology: Genetics of High-Risk/TNBC and African Ances…

Massachusetts General Hospital Cancer Center

L. Newman

11 views
56:23

Environmental Influences on Colorectal Cancer

Massachusetts General Hospital Cancer Center

J. Carethers

19 views
47:34

Confronting Inequity in Modern Therapy for Rare Melanomas

Massachusetts General Hospital Cancer Center

A. Shoushtari

75 views
47:29

Personalizing Care for Older Adults With Cancer

Massachusetts General Hospital Cancer Center

H. Klepin

11 views
50:19

Engineering CAR T-Cells: Combatting Tumor Resistance and Relapse

Massachusetts General Hospital Cancer Center

R. Brentjens

21 views
46:25

Advancing Therapies for Children and Adults With Rare Solid Tumors o…

Massachusetts General Hospital Cancer Center

B. Widemann

7 views
49:26

Turning on Apoptotic Switch in Leukemia: BCL-2 and Beyond

Massachusetts General Hospital Cancer Center

M. Konopleva

22 views
12:33

Endocrine Therapy in EBC: Latest Trial Data on Genomic Testing

Massachusetts General Hospital Cancer Center

N. Davidson

35 views
10:26

Radiation Therapy and Localized PDAC: NACRT vs. NAT, Radiation & Imm…

Massachusetts General Hospital Cancer Center

W. Messersmith, T. Hong

27 views
18:49

RT & laPAC: Application in Unresectable Disease, Dose Escalation & P…

Massachusetts General Hospital Cancer Center

W. Messersmith, T. Hong

16 views
36:51

The Future of Cancer Screening: Non-Standard Screens, Death Rates & …

Massachusetts General Hospital Cancer Center

S. Raoof

25 views
09:54

Augmenting Response to Endocrine Therapy in BC: The Role of Combinat…

Massachusetts General Hospital Cancer Center

N. Davidson

36 views
15:35

ESR1 Mutations and Other Mutational Signatures in HR+/HER2- MBC: Rev…

Massachusetts General Hospital Cancer Center

N. Davidson

425 views
12:39

Key Adjuvant Studies for Resected Pancreatic Adenocarcinoma: What Da…

Massachusetts General Hospital Cancer Center

W. Messersmith, T. Hong

193 views
12:09

The Role of CDK4/6i in Endocrine Therapy of HR+/HER2- MBC: 1/2L Trea…

Massachusetts General Hospital Cancer Center

N. Davidson

309 views
31:20

Understanding Responses to Cancer Therapy: Lessons Learned From Tran…

Massachusetts General Hospital Cancer Center

J. Wargo

8 views
12:43

What Is the Role of Diet in Response to Cancer Treatment?

Massachusetts General Hospital Cancer Center

J. Wargo

134 views
36:18

Molecular Profiling of Gliomas: Therapeutic Utility of Prognostic & …

Massachusetts General Hospital Cancer Center

A. Chakravarti

105 views
22:43

The Use of IO in SCLC: Navigating Established IO Mono & Combination …

Massachusetts General Hospital Cancer Center

T. Owonikoko

138 views

Enhancing the Benefit of IO in SCLC: Considering Emerging Predictive…

Massachusetts General Hospital Cancer Center

T. Owonikoko

98 views
15:48

52 y/o Female With Localized PDAC: How Adequate Is Current Approach?…

Massachusetts General Hospital Cancer Center

W. Messersmith, T. Hong

165 views
48:13

Late Recurrences in ER+ BC: Does Adjuvant ET Decrease the Risk of Re…

Massachusetts General Hospital Cancer Center

D. Hayes

796 views